Author:
Ribes Marta,Montañà Júlia,Vidal Marta,Aguilar Ruth,Nicolás Patricia,Alfonso Uxue,Rodrigo Natalia,Carolis Carlo,Dobaño Carlota,Moncunill Gemma,Chaccour Carlos
Abstract
AbstractThe characterization of the antibody response to SARS-CoV-2 and its determinants are key for the understanding of COVID-19. The identification of vulnerable populations to the infection and to its socioeconomic impact is indispensable for inclusive policies. We conducted an age-stratified cross-sectional community-based seroprevalence survey between June 12th and 19th 2020—during the easing of lockdown—in Cizur, Spain. We quantified IgG, IgM and IgA levels against SARS-CoV-2 spike and its receptor-binding domain in a sample of 728 randomly selected, voluntarily registered inhabitants. We estimated a 7.9% seroprevalence in the general population, with the lowest seroprevalence among children under ten (n = 3/142, 2.1%) and the highest among adolescents (11–20 years old, n = 18/159, 11.3%). We found a heterogeneous immune-response profile across participants regarding isotype/antigen-specific seropositivity, although levels generally correlated. Those with technical education level were the most financially affected. Fifty-five percent had visited a supermarket and 43% a sanitary centre since mid-February 2020. When comparing by gender, men had left the household more frequently. In conclusion, few days after strict lockdown, the burden of SARS-CoV-2 infection was the lowest in children under 10. The findings also suggest that a wider isotype-antigen panel confers higher sensitivity. Finally, the economic impact biases should be considered when designing public health measures.
Funder
AGAUR PhD fellowship from the Catalan Government and the European Social Fund
European Social Fund
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. WHO Coronavirus Disease (COVID-19) Dashboard | WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/.
2. Wang, H. et al. Estimating excess mortality due to the COVID-19 pandemic: A systematic analysis of COVID-19-related mortality, 2020. Lancet 399, 1513–1536 (2022).
3. Mukaigawara, M. et al. An equitable roadmap for ending the COVID-19 pandemic. Nat. Med. 2022, 1–4. https://doi.org/10.1038/s41591-022-01787-2 (2022).
4. Instituto de Salud Pública y Laboral de Navarra. PRIMERA ONDA PANDÉMICA DE COVID-19 EN NAVARRA MARZO A JUNIO DE 2020. (2020).
5. Gobierno de Navarra. Plan y Normas para la Transición. https://gobiernoabierto.navarra.es/es/participacion/transitando-hacia-normalidad/plan-para-transicion (2020).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献